Nasus Pharma Ltd.
NSRX | AMEX
$3.16
-$0.15 (-4.53%)
At close: Oct 30, 2026, 3:59 PM ET
$3.16
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 3:59 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -10.3M | -4.66M | -2.05M | -1.41M | -1.25M | -1.08M | -1.08M | -1.07M | -1.11M | -1.15M | -851.5K | -556K | -278K |
Interest Income | 151.58K | 23.58K | 23.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -10.32M | -4.97M | -2.59M | -1.86M | -1.71M | -1.55M | -1.63M | -1.71M | -1.36M | -1.01M | -594.5K | -184K | -92K |
Net Income | -10.3M | -4.99M | -2.64M | -1.91M | -1.72M | -1.53M | -1.62M | -1.71M | -1.38M | -1.05M | -632.5K | -214K | -107K |
Selling & General & Admin | 5.82M | 2.64M | 1.17M | 956K | 849.5K | 743K | 655.5K | 568K | 574K | 580K | 453.5K | 327K | 163.5K |
Research & Development | 4.47M | 2.03M | 877.95K | 456K | 395.5K | 335K | 420.5K | 506K | 536.5K | 567K | 398K | 229K | 114.5K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.3M | 4.66M | 2.05M | 1.41M | 1.25M | 1.08M | 1.08M | 1.07M | 1.11M | 1.15M | 851.5K | 556K | 278K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.3M | 4.66M | 2.05M | 1.41M | 1.25M | 1.08M | 1.08M | 1.07M | 1.11M | 1.15M | 851.5K | 556K | 278K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.07M | 11M | 9.02M | 7.72M | 7.72M | 7.1M | 7.1M | 6.7M | 6.7M | 7.02M | 7.02M | 2.39M | 2.39M |
Shares Outstanding (Diluted) | 11.07M | 11.07M | 9.02M | 7.36M | 7.36M | 7.17M | 7.17M | 6.89M | 6.89M | 6.89M | 6.89M | 6.89M | 6.89M |
EPS (Basic) | -0.96 | -0.50 | -0.31 | -0.26 | -0.24 | -0.22 | -0.23 | -0.25 | -0.20 | -0.15 | -0.09 | -0.03 | -0.01 |
EPS (Diluted) | -0.96 | -0.50 | -0.31 | -0.26 | -0.24 | -0.22 | -0.24 | -0.25 | -0.23 | -0.21 | -0.15 | -0.09 | -0.04 |
EBITDA | -7.18M | -1.24M | -1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBIT | -10.2M | -4.66M | -2.05M | -1.41M | -1.25M | -1.08M | -1.08M | -1.07M | -1.11M | -1.15M | -851.5K | -556K | -278K |
Depreciation & Amortization | 3.02M | 3.43M | 817K | 1.41M | 1.25M | 1.08M | 1.08M | 1.07M | 1.11M | 1.15M | 851.5K | 556K | 278K |
Add to Watchlist
Select watchlists to add or remove NSRX